# Serological Testing for COVID-19 (SARS-CoV-2) in ESKD

> **NCT04378686** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 500 (actual)

## Conditions studied

- SARS-CoV 2
- End Stage Renal Failure on Dialysis

## Interventions

- **OTHER:** dialysis

## Key facts

- **NCT ID:** NCT04378686
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04378686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04378686, "Serological Testing for COVID-19 (SARS-CoV-2) in ESKD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04378686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*